EBNA1’s presence in all EBV-positive cells, both early and late after infection, further highlights the importance of EBNA1’s ability to directly downregulate NKG2D ligands and assist EBV-positive cells in continuing to evade immune surveillance. The gene discussed is KLRK1; the disease is infection.